Avantax Advisory Services’s DexCom DXCM Stock Holding History

Avantax Advisory Services’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$785K	Sell	8,995 -1,206	-12%	-$94.5K	﹤0.01%	1309
2025 Q1	$697K	Buy	10,201 +3,017	+42%	+$246K	﹤0.01%	1309
2024 Q4	$559K	Buy	7,184 +1,840	+34%	+$136K	﹤0.01%	1367
2024 Q3	$358K	Sell	5,344 -1,715	-24%	-$141K	﹤0.01%	1632
2024 Q2	$800K	Buy	7,059 +3,458	+96%	+$437K	0.01%	1100
2024 Q1	$499K	Buy	3,601 +942	+35%	+$118K	﹤0.01%	1037
2023 Q4	$330K	Buy	+2,659	New	+$272K	﹤0.01%	1193
2020 Q4	–	Sell	-2,212	Closed	-$226K	–	1037
2020 Q3	$226K	Buy	+2,212	New	+$231K	﹤0.01%	1161

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Avantax Advisory Services's DXCM Position: Q2 2025 in Review

Avantax Advisory Services reduced its DexCom (DXCM) stake by 12% in Q2 2025, selling an estimated $94.5K and leaving 8,995 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Avantax Advisory Services first reported a position in DXCM in Q3 2020 and has held it in 8 quarters since. The position peaked at $800K in Q2 2024. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

Avantax Advisory Services held 8,995 shares of DexCom worth $785K as of Q2 2025.
Avantax Advisory Services sold 1,206 DexCom shares in Q2 2025, an estimated $94.5K.
DexCom made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1309 holding.
Avantax Advisory Services first reported a position in DexCom in Q3 2020 and has held it in 8 quarters since.
Avantax Advisory Services's DexCom position peaked at $800K in Q2 2024.
940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.